Analysis of key genes and micro-RNA-mRNA regulatory networks in women with ulcerative interstitial cystitis/pain bladder syndrome
article
OA: closed
CC0
AI-generated summary
Analysis of bladder tissue microarray data identified differentially expressed genes and miRNAs, revealing a regulatory network involving miR-21 and hub genes that may serve as molecular biomarkers for ulcerative interstitial cystitis/painful bladder syndrome.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Introduction and hypothesisThis aim of this study was to better understand ulcerative interstitial cystitis/painful bladder syndrome (IC/PBS) at the molecular level and provide new clues related to diagnosis and treatment.MethodsThe microarray data set GSE11783, including the mRNA and miRNA profiles of bladder tissue obtained at cystoscopic biopsy from patients with ulcerative IC/PBS (presence of at least one Hunner's ulcer) and normal controls, was downloaded from the GEO (Gene Expression Omnibus) database (National Center for Biotechnology Information). These were evaluated using Greenspring GX and Ingenuity Pathway Analysis (IPA) software. The differentially expressed genes (DEGs) and miRNAs (DEMs) in these two groups were identified. Subsequently, the DEGs were subjected to functional analysis, and a protein-protein interaction (PPI) network was constructed. Finally, the miRNA-mRNA regulatory network was visualized using Cystoscope software.ResultsFour DEMs and 1521 DEGs were identified between the ulcerative IC/PBS and control groups. The PPI network of the DEGs was constructed by STRING, which was composed of 393 nodes and 1039 edges, including 221 upregulated genes and 172 downregulated genes. Moreover, 27 genes in the PPI network were identified as hub genes in the IC/PBS group, e.g., PNOC, SSTR1, FPR3, GPR18 and APLNR. Subsequently, 27 clusters were selected from the PPI network using MCODE. It was shown that the most significant cluster consisted of 22 nodes and 231 edges. Moreover, miR-21 was the most significantly upregulated miRNA and was predicted to target one upregulated gene (RASGRP1) and two downregulated genes (KLF5 and SC5D).ConclusionsThe results of this data mining and integration provide further information on the possible molecular basis of IC/PBS pathogenesis as well as potential biomarkers and therapeutic targets for ulcerative IC/PBS diagnosis and treatment.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (31)
- Interstitial Cystitis via openalex
- doi:10.1038/nsmb0906-754 via openalex
- doi:10.1038/377532a0 via openalex
- doi:10.1016/j.juro.2010.06.046 via openalex
- doi:10.1016/s0022-5347(05)66915-7 via openalex
- doi:10.1182/blood-2006-12-062398 via openalex
- doi:10.1016/j.euroneuro.2015.08.015 via openalex
- W2395991175 via openalex
- W4297951998 via openalex
- doi:10.1016/j.pharmthera.2013.10.011 via openalex
- doi:10.1111/ajad.12483 via openalex
- doi:10.3748/wjg.v13.i4.497 via openalex
- doi:10.1097/01.ju.0000146466.71311.ab via openalex
- doi:10.1074/jbc.m707224200 via openalex
- doi:10.1016/j.ajur.2016.08.014 via openalex
- doi:10.1158/0008-5472.can-07-5019 via openalex
- doi:10.1016/j.juro.2006.09.032 via openalex
- doi:10.1073/pnas.0404509101 via openalex
- doi:10.1016/j.cytogfr.2006.09.009 via openalex
- doi:10.1007/s00404-017-4364-2 via openalex
- doi:10.1006/geno.1993.1088 via openalex
- doi:10.2174/138920210793175895 via openalex
- doi:10.1097/mou.0b013e3282fcea88 via openalex
- doi:10.1159/000362946 via openalex
- doi:10.1016/j.juro.2008.01.047 via openalex
- doi:10.1182/blood-2008-01-133355 via openalex
- doi:10.1038/s10038-017-0371-1 via openalex
- doi:10.1016/s0022-5347(01)61948-7 via openalex
- doi:10.1007/s00335-011-9341-7 via openalex
- doi:10.1186/1471-2164-10-199 via openalex
- doi:10.1016/s0022-5347(05)65006-9 via openalex
Source provenance
- openalex
- last seen: 2026-05-11T06:37:04.871248+00:00
License: CC0
· commercial use OK